Browse the corpus

REFERENCES ACT Investigators, “Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results from the Randomized Acetylcysteine for Contrast-induced Nephropathy Trial (ACT),” Circulation , 2011, 124(11):1250-9. [PubMed 21859972 ] Allaqaband S, Tumuluri R, Malik AM, et al, “Prospective Randomized Study of N-Acetylcysteine, Fenoldopam, and Saline for Prevention of Radiocontrast-Induced Nephropathy,” Catheter Cardiovasc Interv , 2002, 57(3):279-83. [PubMed 12410497 ] Appelboam AV, Dargan PI, and Knighton J, “Fatal Anaphylactoid Reaction to N-Acetylcysteine: Caution in Patients With Asthma,” Emerg Med J , 2002, 19(6):594-5. [PubMed 12410497 ] Bailey B and McGuigan MA, “Management of Anaphylactoid Reactions to Intravenous N-Acetylcysteine,” Ann Emerg Med , 1998, 31(6):710-5. [PubMed 12421803 ] Baker CS, Wragg A, Kumar S, et al, "A Rapid Protocol for the Prevention of Contrast-Induced Renal Dysfunction: The RAPPID Study,” J Am Coll Cardiol , 2003, 41(12):2114-8. [PubMed 9624310 ] Briguori C, Airoldi F, D’Andrea D, et al, “Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL). A Randomized Comparison of 3 Preventive Strategies,” Circulation , 2007, 115(10):1211-17. [PubMed 17309916 ] Curhan GC, “Prevention of Contrast Nephropathy,” JAMA , 2003, 289(5):606-8. [PubMed 12821233 ] Dart RC, Erdman AR, Olson KR, et al, “Acetaminophen Poisoning: An Evidence-Based Consensus Guideline for Out-of-Hospital Management,” Clin Toxicol (Phila) , 2006, 44(1):1-18. [PubMed 12578494 ] Douglas D and Smilkstein M, “Deferoxamine-Iron Induced Pulmonary Injury and N-Acetylcysteine,” J Toxicol Clin Toxicol , 1995, 33(5):495. [PubMed 16496488 ] Falk JL, “Oral N-Acetylcysteine Given Intravenously for Acetaminophen Overdose: We Shouldn't Have To, But We Must,” Crit Care Med , 1998, 26(1):7. [PubMed 9428532 ] Harrison PM, Keays R, Bray BP, et al, “Improved Outcome of Paracetamol-Induced Fulminant Hepatic Failure by Late Administration of Acetylcysteine,” Lancet , 1990, 335(8705):1572-3. [PubMed 9428532 ] Toxicology Investigator Network Authorship Group, "A Multicenter Comparison of the Safety of Oral Versus Intravenous Acetylcysteine for Treatment of Acetaminophen Overdose," Clin Toxicol (Phila) , 2010, 48(5):424-30. [PubMed 20524832 ]

Harrison PM, Keays R, Bray BP, et al, “Improved Outcome of Paracetamol-Induced Fulminant Hepatic Failure by Late Administration of Acetylcysteine,” Lancet , 1990, 335(8705):1572-3. [PubMed 9428532 ] Toxicology Investigator Network Authorship Group, "A Multicenter Comparison of the Safety of Oral Versus Intravenous Acetylcysteine for Treatment of Acetaminophen Overdose," Clin Toxicol (Phila) , 2010, 48(5):424-30. [PubMed 20524832 ] Hendrickson RG and Bizovi KE, “Acetaminophen,” Goldfrank's Toxicologic Emergencies , 8th edition, Flomenbaum NE, Goldfrank LR, Hoffman RS, et al, eds, New York: The McGraw-Hill Companies, Inc, 2006, 523-43. Jones AL, “Mechanism of Action and Value of N-Acetylcysteine in the Treatment of Early and Late Acetaminophen Poisoning: A Critical Review,” J Toxicol Clin Toxicol , 1998, 36(4):277-85. [PubMed 9711192 ] Jones AL, “Recent Advances in the Management of Late Paracetamol Poisoning,” Emerg Med , 2000, 12(1):14-21. Kay J, Chow WH, Chan TM, et al, “Acetylcysteine for Prevention of Acute Deterioration of Renal Function Following Elective Coronary Angiography and Intervention: A Randomized Controlled Trial,” JAMA , 2003, 289(5):553-8. [PubMed 7803886 ] Keays R, Harrison PM, Wendon JA, et al, “Intravenous Acetylcysteine in Paracetamol Induced Fulminant Hepatic Failure: A Prospective Controlled Trial,” BMJ , 1991, 303(6809):1026-9. [PubMed 12578487 ] Levine GN, Bates ER, Blankenship JC, et al, “2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions,” Circulation , 2011, 124(23):e574-651. [PubMed 22064601 ] Marenzi G, Assanelli E, Marana I, et al, “N-Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty,” N Engl J Med , 2006, 354(26):2773-82. [PubMed 6807414 ] Mascarenhas MR, “Treatment of Gastrointestinal Problems in Cystic Fibrosis,” Curr Treat Options Gastroenterol , 2003, 6(5):427-41. [PubMed 1954453 ] Mohammed S, Jamal AZ, and Robison LR, “Serum Sickness-Like Illness Associated With N-Acetylcysteine Therapy,” Ann Pharmacother , 1994, 28(2):285. [PubMed 12954149 ] Mokhlesi B, Leikin JB, Murray P, et al, “Adult Toxicology in Critical Care: Part II: Specific Poisonings,” Chest , 2003, 123(3):897-922. [PubMed 12628894 ]

Mascarenhas MR, “Treatment of Gastrointestinal Problems in Cystic Fibrosis,” Curr Treat Options Gastroenterol , 2003, 6(5):427-41. [PubMed 1954453 ] Mohammed S, Jamal AZ, and Robison LR, “Serum Sickness-Like Illness Associated With N-Acetylcysteine Therapy,” Ann Pharmacother , 1994, 28(2):285. [PubMed 12954149 ] Mokhlesi B, Leikin JB, Murray P, et al, “Adult Toxicology in Critical Care: Part II: Specific Poisonings,” Chest , 2003, 123(3):897-922. [PubMed 12628894 ] Mroz L, Benitez JG, and Krenzelok E, “Angioedema With Oral Acetylcysteine,” Ann Emerg Med , 1997, 30(2):240-1. [PubMed 9250658 ] Pakravan N, Waring WS, Sharma S, et al, “Risk Factors and Mechanisms of Anaphylactoid Reactions to Acetylcysteine in Acetaminophen Overdose,” Clin Toxicol , 2008, 46(8):697-702. [PubMed 18803085 ] Prescott LF, Donovan JW, Jarvie DR, et al, “The Disposition and Kinetics of Intravenous N-Acetylcysteine in Patients With Paracetamol Overdosage,” Eur J Clin Pharmacol , 1989, 37(5):501-6. [PubMed 2598989 ] Prescott LF, Illingworth RN, Critchley JA, et al, “Intravenous N-Acetylcysteine: The Treatment of Choice for Paracetamol Poisoning,” BMJ , 1979, 2:1097-1100. [PubMed 2598989 ] Rashid ST, Salman M, Myint F, et al,“Prevention of Contrast-Induced Nephropathy in Vascular Patients Undergoing Angiography: A Randomized Controlled Trial of Intravenous N-Acetylcysteine," J Vasc Surg , 2004, 40(6):1136-41. [PubMed 15622367 ] “Rationale, Design, and Baseline Characteristics of the Acetylcystein for Contrast-Induced NephropaThy (ACT) Trial: A Pragmatic Randomized Controlled Trial to Evaluate the Efficacy of Acetylcysteine for the Prevention of Contrast-Induced Nephropathy,” Trials , 2009, 10:38-45. [PubMed 19497091 ] Rodgers G, Matyunas N, Ross M, et al, “Sulfhemoglobinemia Associated With N-Acetylcysteine (NAC) Therapy of Acetaminophen (APAP) Overdose: A Case Report,” Clin Toxicol , 1995, 33(5):530. [PubMed 15622367 ] Sandilands EA and Bateman DN, “Adverse Reactions Associated With Acetylcysteine,” Clin Toxicol (Phila) , 2009, 47(2):81-8. [PubMed 19280424 ] Schmidt LE, Knudsen TT, Dalhoff K, et al, “Effect of Acetylcysteine on Prothrombin Index in Paracetamol Poisoning Without Hepatocellular Injury,” Lancet , 2002, 360(9340):1151-2. [PubMed 12387966 ]

Sandilands EA and Bateman DN, “Adverse Reactions Associated With Acetylcysteine,” Clin Toxicol (Phila) , 2009, 47(2):81-8. [PubMed 19280424 ] Schmidt LE, Knudsen TT, Dalhoff K, et al, “Effect of Acetylcysteine on Prothrombin Index in Paracetamol Poisoning Without Hepatocellular Injury,” Lancet , 2002, 360(9340):1151-2. [PubMed 12387966 ] Smilkstein MJ, Bronstein AC, Linden C, “Acetaminophen Overdose: A 48-Hour Intravenous N-Acetylcysteine Treatment Protocol," Ann Emerg Med , 1991, 20(10):1058-63. [PubMed 1928874 ] Smilkstein MJ, Knapp GL, Kulig KW, et al, “Efficacy of N-Acetylcysteine in the Treatment of Acetaminophen Overdose: Analysis of the National Multicenter Study (1976 to 1985),” N Engl J Med , 1988, 319(24):1557-62. [PubMed 1928874 ] Tepel M, van der Giet M, Schwarzfeld C, et al, “Prevention of Radiographic-Contrast-Agent-Induced Reductions in Renal Function by Acetylcysteine,” N Engl J Med , 2000, 343(3):180-4. [PubMed 3059186 ] Walson PD and Groth JF Jr, “Acetaminophen Hepatotoxicity After Prolonged Ingestion,” Pediatrics , 1993, 91(5):1021-2. [PubMed 10900277 ] Waring WS, Stephen AF, Robinson OD, et al,“Lower Incidence of Anaphylactoid Reactions to N-Acetylcysteine in Patients With High Acetaminophen Concentrations After Overdose,” Clin Toxicol (Phila) , 2008, 46(6):496-500. [PubMed 18584360 ] Webb JG, Pate GE, Humphries KH, et al, “A Randomized Controlled Trial of Intravenous N-Acetylcysteine for the Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization: Lack of Effect,” Am Heart J , 2004, 148(3):422-9. [PubMed 15389228 ] Woo OF, Anderson IB, Kim SY, et al, “Shorter Duration of N-Acetylcysteine (NAC) for Acute Acetaminophen Poisoning,” Clin Toxicol , 1995, 33(5):508. [PubMed 15389228 ] Woo OF, Mueller PD, Olson KR, et al, “Shorter Duration of Oral N-Acetylcysteine Therapy for Acute Acetaminophen Overdose,” Ann Emerg Med , 2000, 35(4):363-8. [PubMed 10736123 ] Yankaskas JR, Marshall BC, Sufian B, et al, “Cystic Fibrosis Adult Care: Consensus Conference Report,” Chest , 2004, 125(1 Suppl):1-39. [PubMed 10736123 ] Yip L, Dart RC, and Hurlbut KM, “Intravenous Administration of Oral N-Acetylcysteine,” Crit Care Med , 1998, 26(1):40-3. [PubMed 14718408 ] Zyoud SH, Awang R, Sulaiman SA, et al, “Incidence of Adverse Drug Reactions Induced by N-Acetylcysteine in Patients With Acetaminophen Overdose,” Hum Exp Toxicol , 2010, 29(3):153-60. [PubMed 20071472 ]

Yip L, Dart RC, and Hurlbut KM, “Intravenous Administration of Oral N-Acetylcysteine,” Crit Care Med , 1998, 26(1):40-3. [PubMed 14718408 ] Zyoud SH, Awang R, Sulaiman SA, et al, “Incidence of Adverse Drug Reactions Induced by N-Acetylcysteine in Patients With Acetaminophen Overdose,” Hum Exp Toxicol , 2010, 29(3):153-60. [PubMed 20071472 ] Zyoud SH, Awang R, Sulaiman SA, et al, “N-Acetylcysteine-Induced Headache in Hospitalized Patients With Acute Acetaminophen Overdose,” Fundam Clin Pharmacol , 2011, 25(3):405-10. [PubMed 20584210 ] Topic 9317 Version 42.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1003-200.131.240.2-0CE6B713CC-S244013.14]